Valuation: Perrigo Company plc

Market Cap 1.99B 1.74B 1.64B 1.5B 2.8B 190B 2.82B 19.68B 7.63B 96.98B 7.46B 7.29B 314B P/E 2026 *
1,431x
P/E 2027 * 11.9x
Enterprise Value 4.89B 4.29B 4.03B 3.69B 6.89B 468B 6.94B 48.46B 18.79B 239B 18.36B 17.96B 774B EV / Sales 2026 *
1.2x
EV / Sales 2027 * 1.17x
Free-Float
99.6%
Yield 2026 *
8.08%
Yield 2027 * 8.29%
1 day-2.34%
1 week+2.77%
Current month-4.95%
1 month-2.49%
3 months+46.63%
6 months+45.40%
Current year-0.04%
1 week 13.15
Extreme 13.15
14.46
1 month 13.15
Extreme 13.15
15
Current year 9.22
Extreme 9.225
15.38
1 year 9.22
Extreme 9.225
22.65
3 years 9.22
Extreme 9.225
34.6
5 years 9.22
Extreme 9.225
50.9
10 years 9.22
Extreme 9.225
98.15
Manager TitleAgeSince
Chief Executive Officer 63 07/06/2026
Director of Finance/CFO 51 16/05/2022
Chief Operating Officer - 23/06/2025
Director TitleAgeSince
Director/Board Member 75 01/11/2014
Director/Board Member 61 07/11/2016
Director/Board Member 70 06/02/2017
Date Insider Type Main position Quantity % Market Cap. Importance
11/09/26 Exercice

Director

5,192 0.0037%
11/09/26 Exercice

Director

3,133 0.0023%
09/09/26 Exercice

Executive/Senior Manager

18,186 0.0131%
Change 5-day change 1-year change 3-year change Capi.($)
-2.52%+2.77%-34.08%-56.77% 1.99B
-1.87%+1.05%+53.92%+108.18% 1,043B
-0.50%+0.30%+51.82%+67.28% 649B
-0.16%+0.98%+19.08%+71.41% 469B
-0.25%+0.19%+36.95%+45.54% 355B
+0.98%+2.91%+20.59%+27.14% 270B
-1.91%+2.42%+10.41%+11.04% 262B
-0.93%+8.00%+41.71%+52.30% 222B
-1.38%+2.03%+31.71%+101.36% 189B
-2.53%-7.47%-32.63%-60.41% 175B
Average -1.03%+2.53%+19.95%+36.71% 363.5B
Weighted average by Cap. -0.93%+2.19%+35.67%+65.04%

Financials

2026 *2027 *
Net sales 4.06B 3.56B 3.35B 3.06B 5.72B 389B 5.76B 40.23B 15.6B 198B 15.24B 14.91B 643B 4.09B 3.59B 3.37B 3.08B 5.76B 392B 5.81B 40.52B 15.71B 200B 15.36B 15.02B 648B
Net income -224M -197M -185M -169M -316M -21.47B -318M -2.22B -861M -10.94B -842M -823M -35.49B -56.95M -49.99M -46.99M -42.96M -80.27M -5.46B -80.87M -564M -219M -2.78B -214M -209M -9.02B
Net Debt 2.9B 2.55B 2.4B 2.19B 4.09B 278B 4.12B 28.78B 11.16B 142B 10.91B 10.67B 460B 2.78B 2.44B 2.3B 2.1B 3.92B 267B 3.95B 27.59B 10.69B 136B 10.45B 10.22B 441B
Logo Perrigo Company plc
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
8,100
Date Price Change Volume
23/09/26 $13.95 -2.52% 564,083
22/09/26 $14.31 +1.27% 2,322,380
21/09/26 $14.13 +4.20% 1,709,346
18/09/26 $13.56 +0.59% 6,878,268
17/09/26 $13.48 -0.44% 2,247,845
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
14.31USD
Average target price
16.50USD
Spread / Average Target
+15.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PRGO Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!